Concord Biotech informs about updates

18 Jul 2025 Evaluate

Concord Biotech has informed regarding the successful completion of the European Union Good Manufacturing Practice (EU GMP) inspection at Active Pharmaceutical Ingredient (API) manufacturing facility located in Dholka, Gujarat. The inspection was conducted from July 14’ 2025 to July 18’ 2025. This achievement underscores its unwavering commitment to upholding the highest standards of quality, safety, and regulatory compliance across all aspects of its operations. It reflects its dedication to excellence and its continued focus on meeting the rigorous requirements of global regulatory authorities.

The above information is a part of company’s filings submitted to BSE.

Concord Biotech Share Price

1339.30 171.70 (14.71%)
06-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1694.70
Dr. Reddys Lab 1241.15
Cipla 1330.80
Zydus Lifesciences 887.85
Lupin 2168.35
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×